From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer

By Samuel Limat  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 633-641

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain

By Plans-Rubió Pedro  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A.   Carr Emma   Lewis Gavin   Marcus Robert  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy

By Nordmann A.J.   Krahn M.   Logan A.G.   Naglie G.   Detsky A.S.  

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 573-585

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma

By Rutten-van Mölken M.P.M.H.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 671-684

Adis International

Access to resources Recommend Favorite